SCHEMBL5484094

SCHEMBL5484094

N=C(N)c1ccc(C(F)(F)F)nc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV4 Q9HBA0 1/20 0.48
UBE2T Q9NPD8 2/20 0.45
LMNA P02545 2/20 0.39
PLAU P00749 2/20 0.39
MASP2 O00187 1/20 0.39
THPO P40225 1/20 0.39
PRSS1 P07477 3/20 0.38
F2 P00734 3/20 0.38
PRSS3 P35030 2/20 0.38
APEX1 P27695 1/20 0.38
PRSS2 P07478 1/20 0.37
KLKB1 P03952 1/20 0.37
ST14 Q9Y5Y6 1/20 0.36
PRMT5 O14744 1/20 0.36
PRMT1 Q99873 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
CYP2C19 P33261 1/20 0.36
HSD17B10 Q99714 1/20 0.36
FURIN P09958 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4394798 0.98 TRPV4 (0.47) TRPV4UBE2TLMNAPLAUMASP2
Hydrochloric Acid SCHEMBL30936029 0.98 TRPV4 (0.47) TRPV4UBE2TLMNAPLAUMASP2
Hydrochloric Acid SCHEMBL25304395 0.96 TRPV4 (0.46) TRPV4UBE2TLMNAPLAUMASP2
SCHEMBL28558708 0.81 TRPV4 (0.48) TRPV4KCNH2
SCHEMBL29827501 0.81 TRPV4 (0.48) TRPV4ALDH1A1MAP4K4PIK3CAKCNH2
SCHEMBL2516351 0.81 NNMT (0.55) TRPV4
SCHEMBL29447043 0.81 NNMT (0.55) TRPV4
SCHEMBL2307150 0.81 TRPV4 (0.48) TRPV4ALDH1A1MAP4K4PIK3CAKCNH2
SCHEMBL14206340 0.81 TRPV4 (0.48) TRPV4MAP4K4PIK3CAKCNH2MINK1
SCHEMBL12227502 0.81 UBE2T (0.45) UBE2TLMNAPLAUMASP2THPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12043615-B2 Fluorine-containing pyrimidine compound and method for manufacturing the same UNIMATEC CO., LTD. (JP) 2024-07-23 US disclosed
US-12043615-B2 Fluorine-containing pyrimidine compound and method for manufacturing the same UNIMATEC CO., LTD. (JP) 2024-07-23 US disclosed
US-20210403455-A1 FLUORINE-CONTAINING PYRIMIDINE COMPOUND AND METHOD FOR MANUFACTURING THE SAME UNIMATEC CO., LTD. (JP) 2021-12-30 US disclosed
US-7226927-B2 Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators of caspases and inducers of apoptosis and the use thereof CYTOVIA, INC. (US) 2007-06-05 US disclosed
EP-0902026-B1 Herbicidal 2-azinyl-6-aryloxypyr(mi)dines BASF AG (DE) 2006-04-12 EP disclosed
EP-1351691-A4 SUBSTITUTED 2-ARYL-4-ARYLAMINOPYRIMIDINES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF CYTOVIA INC (US) 2005-06-22 EP disclosed
US-20040097503-A1 Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators of caspases and inducers of apoptosis and the use thereof CYTOVIA, INC. 2004-05-20 US disclosed
US-6716851-B2 ANTICANCER AGENTS CYTOVIA, INC. 2004-04-06 US disclosed
EP-1351691-A1 SUBSTITUTED 2-ARYL-4-ARYLAMINOPYRIMIDINES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF Cytovia, Inc. (US) 2003-10-15 EP disclosed
US-20030069239-A1 Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators or caspases and inducers of apoptosis and the use thereof CYTOVIA, INC. 2003-04-10 US disclosed
WO-2002047690-A1 SUBSTITUTED 2-ARYL-4-ARYLAMINOPYRIMIDINES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF CYTOVIA, INC. (US) 2002-06-20 WO disclosed
EP-0902026-A1 Herbicidal 2-azinyl-6-aryloxypyr (mi) dines American Cyanamid Company (US) 1999-03-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12043615-B2 Fluorine-containing pyrimidine compound and method for manufacturing the same CNOT1, NUDT1, XRN2 TRPV4 4596/4885UBE2T 2732/4885LMNA 2304/4885
US-20210403455-A1 FLUORINE-CONTAINING PYRIMIDINE COMPOUND AND METHOD FOR MANUFACTURING THE SAME CNOT1, NUDT1, XRN2 TRPV4 4596/4885UBE2T 2732/4885LMNA 2304/4885
US-20030069239-A1 Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators or caspases and inducers of apoptosis and the use thereof API5, CASP2, APAF1 TRPV4 2430/4885UBE2T 1500/4885LMNA 1814/4885
US-20040097503-A1 Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators of caspases and inducers of apoptosis and the use thereof API5, CASP2, APAF1 TRPV4 2462/4885UBE2T 1489/4885LMNA 1848/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.